Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Depreciation and Depletion (2019 - 2025)

Historic Depreciation and Depletion for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $300000.0.

  • Pulmonx's Depreciation and Depletion changed 0.0% to $300000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 1666.67%. This contributed to the annual value of $1.1 million for FY2024, which is 2142.86% down from last year.
  • Per Pulmonx's latest filing, its Depreciation and Depletion stood at $300000.0 for Q3 2025, which was down 0.0% from $300000.0 recorded in Q2 2025.
  • Pulmonx's Depreciation and Depletion's 5-year high stood at $400000.0 during Q4 2022, with a 5-year trough of $100000.0 in Q1 2021.
  • For the 5-year period, Pulmonx's Depreciation and Depletion averaged around $273684.2, with its median value being $300000.0 (2021).
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first soared by 20000.0% in 2022, then plummeted by 6666.67% in 2024.
  • Pulmonx's Depreciation and Depletion (Quarter) stood at $300000.0 in 2021, then surged by 33.33% to $400000.0 in 2022, then dropped by 25.0% to $300000.0 in 2023, then plummeted by 66.67% to $100000.0 in 2024, then surged by 200.0% to $300000.0 in 2025.
  • Its Depreciation and Depletion stands at $300000.0 for Q3 2025, versus $300000.0 for Q2 2025 and $300000.0 for Q1 2025.